IVF Stock Overview
A healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
INVO Fertility, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.68 |
| 52 Week High | US$14.88 |
| 52 Week Low | US$1.38 |
| Beta | 0 |
| 1 Month Change | -23.64% |
| 3 Month Change | -62.64% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -86.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| IVF | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -22.9% | -3.9% | -2.7% |
| 1Y | n/a | 6.8% | 9.1% |
Return vs Industry: Insufficient data to determine how IVF performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how IVF performed against the US Market.
Price Volatility
| IVF volatility | |
|---|---|
| IVF Average Weekly Movement | 27.4% |
| Medical Equipment Industry Average Movement | 9.3% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 4.2% |
Stable Share Price: IVF's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: IVF's weekly volatility has increased from 21% to 27% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 35 | Steve Shum | www.invobioscience.com |
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body.
INVO Fertility, Inc. Fundamentals Summary
| IVF fundamental statistics | |
|---|---|
| Market cap | US$3.61m |
| Earnings (TTM) | -US$25.15m |
| Revenue (TTM) | US$6.59m |
Is IVF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IVF income statement (TTM) | |
|---|---|
| Revenue | US$6.59m |
| Cost of Revenue | US$3.85m |
| Gross Profit | US$2.74m |
| Other Expenses | US$27.89m |
| Earnings | -US$25.15m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -11.70 |
| Gross Margin | 41.57% |
| Net Profit Margin | -381.52% |
| Debt/Equity Ratio | 193.8% |
How did IVF perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/27 19:45 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
INVO Fertility, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason McCarthy | Maxim Group |